1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Torres, A.M. De Plater, G.M. Doverskog, M. C Birinyi-Strachan, L. Nicholson, G.M. Gallagher, C.H. Kuchel, P.W. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK Biochem.J. BIJOAK 0043 0264-6021 348 649 656 10.1042/0264-6021:3480649 10839998 Defensin-like peptide-2 from platypus venom: member of a class of peptides with a distinct structural fold. 2000 UK Biochem.J. BIJOAK 0043 0264-6021 341 785 794 10.1042/0264-6021:3410785 Solution Structure of a Defensin-Like Peptide From Platypus Venom 1999 US Biochemistry BICHAW 0033 0006-2960 34 13663 13671 Solution Structure of Bovine Neutrophil Beta-Defensin-12: The Peptide Fold of the Beta-Defensins is Identical to That of the Classical Defensins 1995 10.2210/pdb1d6b/pdb pdb_00001d6b 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 5121.899 DEFENSIN-LIKE PEPTIDE-2 1 nat polymer no no IMFFEMQACWSHSGVCRDKSERNCKPMAWTYCENRNQKCCEY IMFFEMQACWSHSGVCRDKSERNCKPMAWTYCENRNQKCCEY A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n platypus Ornithorhynchus sample 9258 SPUR Ornithorhynchus anatinus VENOM VENOM GLAND database_2 pdbx_nmr_software pdbx_nmr_spectrometer pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2000-06-21 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _pdbx_nmr_spectrometer.model RCSB Y RCSB 1999-10-12 REL REL THE STRUCTURES WERE DETERMINED USING STANDARD 2D HOMONUCLEAR TECHNIQUES. LOWEST ENERGY 4800 20 2D NOESY NO SALT ADDED 3.6 AMBIENT 298 K THE STRUCTURES ARE BASED ON A TOTAL OF 739 RESTRAINTS, 699 ARE NOE-DERIVED DISTANCE RESTRAINTS, 24 DIHEDRAL ANGLE RESTRAINTS, 16 DISTANCE RESTRAINTS FROM HYDROGEN BONDS. DISTANCE GEOMETRY, SIMULATED ANNEALING, MOLECULAR DYNAMICS, TORSION ANGLE DYNAMICS 1 lowest energy 1MM DLP-2 BRUKER processing XwinNMR 2.5 BARTELS, C., XIA, T., BILLETER, M., GUNTERT, P., WUTHRICH, K. data analysis XEASY 1.3.13 GUNTERT, P., MUMENTHALER, C., WUHTRICH, K. structure solution DYANA 1.5 BRUNGER refinement X-PLOR 3.843 600 Bruker AVANCE ILE 1 n 1 ILE 1 A MET 2 n 2 MET 2 A PHE 3 n 3 PHE 3 A PHE 4 n 4 PHE 4 A GLU 5 n 5 GLU 5 A MET 6 n 6 MET 6 A GLN 7 n 7 GLN 7 A ALA 8 n 8 ALA 8 A CYS 9 n 9 CYS 9 A TRP 10 n 10 TRP 10 A SER 11 n 11 SER 11 A HIS 12 n 12 HIS 12 A SER 13 n 13 SER 13 A GLY 14 n 14 GLY 14 A VAL 15 n 15 VAL 15 A CYS 16 n 16 CYS 16 A ARG 17 n 17 ARG 17 A ASP 18 n 18 ASP 18 A LYS 19 n 19 LYS 19 A SER 20 n 20 SER 20 A GLU 21 n 21 GLU 21 A ARG 22 n 22 ARG 22 A ASN 23 n 23 ASN 23 A CYS 24 n 24 CYS 24 A LYS 25 n 25 LYS 25 A PRO 26 n 26 PRO 26 A MET 27 n 27 MET 27 A ALA 28 n 28 ALA 28 A TRP 29 n 29 TRP 29 A THR 30 n 30 THR 30 A TYR 31 n 31 TYR 31 A CYS 32 n 32 CYS 32 A GLU 33 n 33 GLU 33 A ASN 34 n 34 ASN 34 A ARG 35 n 35 ARG 35 A ASN 36 n 36 ASN 36 A GLN 37 n 37 GLN 37 A LYS 38 n 38 LYS 38 A CYS 39 n 39 CYS 39 A CYS 40 n 40 CYS 40 A GLU 41 n 41 GLU 41 A TYR 42 n 42 TYR 42 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O ARG 17 A O ARG 17 A N LYS 38 A N LYS 38 1 A A HG2 HB2 GLU CYS 21 24 1.18 1 A A HG3 H GLU ASN 21 23 1.25 1 A A HG12 H VAL CYS 15 16 1.28 3 A A HG2 HB2 GLU CYS 21 24 1.19 3 A A HB3 H MET GLN 6 7 1.28 3 A A HA HE2 CYS HIS 9 12 1.32 3 A A HG3 H GLU ASN 21 23 1.33 4 A A HG3 H GLU ASN 21 23 1.23 4 A A HA HG3 LYS LYS 19 38 1.24 5 A A HG2 HB2 GLU CYS 21 24 1.16 5 A A HG3 H GLU ASN 21 23 1.22 5 A A OE2 O GLU ASN 21 23 2.18 6 A A HG2 HB2 GLU CYS 21 24 1.19 6 A A HG3 H GLU ASN 21 23 1.28 6 A A OE2 O GLU ASN 21 23 2.17 7 A A HG3 HB2 LYS GLU 25 41 1.28 9 A A HB3 HD3 LYS LYS 19 38 1.20 9 A A HE2 HA MET GLU 27 41 1.20 9 A A HB2 H LYS GLU 25 41 1.22 11 A A HD21 H ASN ASN 34 36 1.26 12 A A HB3 H PHE PHE 3 4 1.26 13 A A HB3 HZ1 CYS LYS 24 38 1.34 14 A A HB2 HB2 CYS CYS 16 32 1.34 17 A A HB2 H LYS GLU 25 41 1.18 17 A A HD3 H LYS SER 19 20 1.28 18 A A H HA GLN THR 7 30 1.22 18 A A HG3 HB3 LYS GLU 25 41 1.26 18 A A HB2 HG23 GLN THR 7 30 1.27 20 A A HG2 HG2 LYS LYS 19 38 1.20 20 A A HG2 H MET THR 6 30 1.27 20 A A HB3 HB2 ASN GLN 34 37 1.27 20 A A HG12 H VAL CYS 15 16 1.34 1 A MET 2 70.75 -165.70 1 A PHE 4 154.55 -119.04 1 A GLU 5 13.82 84.26 1 A MET 6 -43.99 -108.66 1 A ALA 8 -23.11 115.83 1 A SER 13 81.05 72.82 1 A ASP 18 -35.54 133.30 1 A ALA 28 -47.04 176.26 1 A TRP 29 40.17 73.81 1 A THR 30 159.14 137.01 1 A ARG 35 -67.06 12.88 1 A GLU 41 -50.69 -73.01 2 A MET 2 -51.73 77.58 2 A PHE 3 -137.50 -126.66 2 A PHE 4 86.22 76.50 2 A GLU 5 -1.85 69.28 2 A MET 6 -36.74 -93.83 2 A ALA 8 -21.78 129.69 2 A PRO 26 -44.22 96.29 2 A ALA 28 -62.71 -171.58 2 A TRP 29 40.10 75.44 2 A THR 30 162.88 157.49 2 A ARG 35 -60.12 17.52 2 A GLU 41 -42.63 -74.01 3 A PHE 3 -102.22 65.29 3 A MET 6 -52.91 -134.66 3 A ALA 8 -30.80 103.35 3 A CYS 9 -31.20 -25.95 3 A SER 13 61.78 77.43 3 A PRO 26 -47.66 99.92 3 A ALA 28 -52.44 177.58 3 A TRP 29 39.76 72.89 3 A THR 30 165.11 150.06 3 A ARG 35 -64.99 12.48 3 A GLU 41 -56.24 -76.10 4 A PHE 4 67.32 109.89 4 A GLU 5 170.70 83.45 4 A MET 6 -54.60 -138.70 4 A GLN 7 -127.18 -149.59 4 A CYS 9 -33.60 -24.60 4 A SER 11 -56.30 10.05 4 A SER 13 89.51 65.51 4 A PRO 26 -52.86 108.49 4 A MET 27 -103.39 76.15 4 A ALA 28 -46.54 -166.74 4 A TRP 29 36.34 66.11 4 A THR 30 153.09 147.87 4 A ARG 35 -66.52 15.65 5 A PHE 3 -98.49 39.46 5 A PHE 4 -93.90 56.51 5 A MET 6 -50.01 -157.35 5 A ALA 8 -35.11 126.08 5 A PRO 26 -37.13 110.19 5 A ALA 28 -51.62 -176.41 5 A TRP 29 37.43 72.16 5 A THR 30 160.72 133.25 5 A TYR 31 -117.84 -169.93 5 A GLU 41 -51.53 -72.14 6 A MET 2 44.19 99.87 6 A PHE 4 18.13 81.14 6 A GLU 5 162.30 122.36 6 A MET 6 -77.79 -126.96 6 A SER 13 39.29 63.42 6 A ASP 18 -30.80 148.52 6 A PRO 26 -37.68 99.19 6 A ALA 28 -66.09 -174.08 6 A TRP 29 37.84 74.63 6 A THR 30 154.55 148.60 6 A GLU 41 -50.70 -90.94 7 A MET 2 88.13 151.47 7 A PHE 3 -145.09 -85.94 7 A PHE 4 -144.11 -139.29 7 A GLU 5 48.40 100.53 7 A MET 6 -66.63 -113.07 7 A ALA 8 -29.22 118.61 7 A SER 13 40.02 73.71 7 A ASP 18 -35.67 133.33 7 A LYS 25 -39.43 102.69 7 A PRO 26 -58.90 107.59 7 A TRP 29 39.09 72.91 7 A THR 30 165.65 145.13 8 A PHE 3 -119.94 -99.59 8 A GLU 5 171.10 50.61 8 A MET 6 -67.93 -99.06 8 A SER 13 72.40 76.67 8 A ARG 17 -128.48 -166.28 8 A LYS 19 -58.95 15.27 8 A GLU 21 -36.24 148.65 8 A ASN 23 -141.94 44.04 8 A PRO 26 -42.16 108.11 8 A ALA 28 -54.96 -170.67 8 A TRP 29 40.21 74.03 8 A THR 30 160.41 157.33 9 A MET 2 24.80 88.56 9 A PHE 4 -27.26 88.08 9 A GLU 5 170.89 119.69 9 A MET 6 -69.18 -119.76 9 A ALA 8 -23.43 105.56 9 A CYS 9 -29.78 -28.98 9 A SER 13 83.61 64.60 9 A SER 20 -60.47 10.30 9 A LYS 25 -51.44 99.33 9 A PRO 26 -41.99 93.50 9 A TRP 29 37.87 73.04 9 A THR 30 172.79 135.52 10 A PHE 4 -71.18 37.64 10 A GLU 5 -99.90 59.03 10 A MET 6 -59.52 -113.33 10 A ALA 8 -23.50 139.95 10 A SER 13 25.60 61.85 10 A ASP 18 -30.33 127.66 10 A LYS 19 -43.82 -13.77 10 A ASN 23 -109.51 71.16 10 A LYS 25 -55.57 109.83 10 A PRO 26 -40.92 94.89 10 A ALA 28 -56.99 -168.93 10 A TRP 29 39.90 74.30 10 A THR 30 162.89 148.11 10 A CYS 32 -109.38 -162.21 11 A PHE 4 -162.38 58.40 11 A GLU 5 -166.87 91.54 11 A MET 6 -74.98 -150.54 11 A GLN 7 -141.89 -125.11 11 A CYS 9 -35.62 -25.36 11 A SER 11 -48.61 -19.77 11 A SER 13 82.32 70.23 11 A ASP 18 -35.47 134.20 11 A LYS 25 -57.25 102.22 11 A PRO 26 -43.64 98.72 11 A MET 27 -105.54 78.11 11 A ALA 28 -48.68 -171.06 11 A TRP 29 38.34 73.83 11 A THR 30 159.41 142.36 11 A CYS 32 -111.56 -159.36 11 A GLU 41 -29.73 -55.85 12 A MET 2 -20.17 141.06 12 A PHE 3 -124.12 -125.77 12 A PHE 4 -158.25 12.73 12 A GLU 5 -107.57 59.98 12 A MET 6 -70.50 -100.77 12 A ALA 8 -32.91 120.37 12 A CYS 9 -33.63 -28.44 12 A SER 11 -36.56 -32.62 12 A SER 13 76.33 81.87 12 A LYS 19 -49.65 -4.14 12 A CYS 24 -107.61 78.92 12 A LYS 25 -47.08 104.09 12 A PRO 26 -45.85 100.90 12 A ALA 28 -65.51 -179.87 12 A TRP 29 37.16 71.49 12 A THR 30 162.69 136.69 12 A ARG 35 -58.33 14.90 12 A GLU 41 -30.77 -84.40 13 A PHE 3 -126.48 -124.70 13 A GLU 5 -160.87 106.78 13 A MET 6 -55.71 -111.44 13 A ALA 8 -32.48 114.58 13 A CYS 9 -36.29 -28.05 13 A SER 11 -39.35 -26.87 13 A SER 13 78.84 67.71 13 A LYS 19 -31.51 -37.08 13 A SER 20 -78.15 21.56 13 A ASN 23 -116.69 69.83 13 A LYS 25 -42.85 104.74 13 A PRO 26 -45.44 98.55 13 A ALA 28 -57.09 -175.37 13 A TRP 29 37.78 73.50 13 A THR 30 160.38 138.08 13 A ARG 35 -63.40 11.59 13 A GLU 41 -41.58 -72.60 14 A PHE 4 -167.45 -128.94 14 A GLU 5 64.01 108.19 14 A MET 6 -70.49 -166.11 14 A SER 13 59.32 78.12 14 A ASP 18 -32.91 140.31 14 A LYS 19 -59.36 8.42 14 A LYS 25 -58.65 100.73 14 A PRO 26 -43.41 95.38 14 A ALA 28 -50.15 -168.98 14 A TRP 29 34.31 66.73 14 A THR 30 150.21 140.42 14 A TYR 31 -112.07 -158.94 14 A ARG 35 -61.91 17.62 15 A MET 2 69.21 64.31 15 A PHE 3 -93.55 -80.75 15 A PHE 4 -108.23 -153.61 15 A GLU 5 66.38 106.89 15 A MET 6 -59.64 -154.93 15 A ALA 8 -12.79 110.66 15 A CYS 9 -26.59 -32.02 15 A SER 11 -49.53 3.92 15 A SER 13 91.99 70.63 15 A LYS 19 -58.38 -1.47 15 A PRO 26 -48.82 99.25 15 A TRP 29 36.85 71.78 15 A ARG 35 -67.21 16.17 15 A GLU 41 -26.12 -55.41 16 A MET 2 175.47 -149.27 16 A PHE 3 -149.00 -127.45 16 A PHE 4 28.39 52.23 16 A GLU 5 -157.93 67.04 16 A MET 6 -62.07 -155.96 16 A CYS 9 -35.29 -25.29 16 A SER 11 -29.86 -27.24 16 A SER 13 85.85 80.09 16 A ASP 18 -29.77 134.71 16 A LYS 19 -60.90 12.27 16 A PRO 26 -41.03 103.29 16 A ALA 28 -56.08 -176.44 16 A TRP 29 36.25 72.56 16 A THR 30 152.80 145.61 16 A CYS 32 -100.65 -169.63 16 A ARG 35 -60.07 14.90 16 A GLU 41 -53.84 -82.40 17 A PHE 3 -134.62 -65.25 17 A MET 6 -96.34 -155.17 17 A ALA 8 -27.47 121.95 17 A SER 11 -51.80 -3.43 17 A SER 13 29.72 64.46 17 A ASP 18 -39.51 140.07 17 A LYS 25 -58.21 105.79 17 A PRO 26 -44.99 86.48 17 A ALA 28 -66.57 -172.58 17 A TRP 29 38.43 73.91 17 A THR 30 172.68 146.15 18 A PHE 4 -46.50 75.38 18 A MET 6 -56.71 -172.98 18 A ALA 8 -43.14 109.61 18 A CYS 9 -29.32 -28.17 18 A SER 11 -49.40 1.15 18 A SER 13 77.41 71.86 18 A LYS 19 -48.89 -2.31 18 A ASN 23 -114.35 70.50 18 A LYS 25 -54.98 106.74 18 A PRO 26 -50.28 108.66 18 A ALA 28 -75.64 -156.45 18 A TRP 29 21.28 39.91 18 A ARG 35 -61.89 7.18 19 A MET 2 69.76 139.66 19 A GLU 5 -107.02 75.04 19 A MET 6 -79.65 -115.40 19 A ALA 8 -37.67 115.13 19 A CYS 9 -33.11 -33.04 19 A SER 11 -60.06 0.67 19 A PRO 26 -50.19 99.23 19 A TRP 29 38.13 74.49 19 A THR 30 162.73 153.34 20 A MET 2 23.96 52.78 20 A PHE 3 -145.52 -13.63 20 A PHE 4 73.19 49.18 20 A GLU 5 -103.43 46.16 20 A MET 6 -48.55 -173.61 20 A ALA 8 -33.35 117.25 20 A CYS 9 -34.82 -29.03 20 A SER 13 85.99 65.09 20 A LYS 19 -34.16 -20.62 20 A LYS 25 -54.97 104.96 20 A PRO 26 -45.87 93.37 20 A ALA 28 -67.31 -170.72 20 A TRP 29 38.21 73.60 20 A THR 30 159.22 138.51 20 A CYS 32 -101.65 -167.87 SOLUTION STRUCTURE OF DEFENSIN-LIKE PEPTIDE-2 (DLP-2) FROM PLATYPUS VENOM 1 N N A ALA 8 A ALA 8 HELX_P A SER 13 A SER 13 1 1 6 disulf 2.029 A CYS 9 A SG CYS 9 1_555 A CYS 39 A SG CYS 39 1_555 disulf 2.030 A CYS 16 A SG CYS 16 1_555 A CYS 32 A SG CYS 32 1_555 disulf 2.030 A CYS 24 A SG CYS 24 1_555 A CYS 40 A SG CYS 40 1_555 TOXIN HELIX, ANTIPARALLEL BETA-SHEET, TOXIN DLP2_ORNAN UNP 1 1 P82140 1 42 1D6B 1 42 P82140 A 1 1 42 2 anti-parallel A VAL 15 A VAL 15 A ASP 18 A ASP 18 A GLN 37 A GLN 37 A CYS 40 A CYS 40 1 P 1